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Background: Chemoprevention crossover trials of tea can be more efficient than parallel designs but the attrition
and compliance rates with such trials are unknown.
Methods: Attrition (dropouts) and compliance with treatment were assessed in a 25-week randomized, placebo
controlled, crossover, feasibility clinical trial of four tea treatments to investigate the effect of tea on oral cancer
biomarkers. Each treatment lasted 4 weeks with 2 weeks of washout in between. Participants were 32 smokers and
33 non-smokers without any evidence of premalignant oral lesions. The interventions consisted of packets of green
tea, black tea, caffeinated water, or placebo. Participants were assigned to each treatment for four weeks, and were
instructed to drink five packets per day while on the treatment. Dropout from the trial and compliance
(consumption of≥ 85% of the prescribed treatment packets) are the main outcome measures reported.
Results: There was a high rate of dropout (51%) from the study, and the rates were significantly higher among
smokers (64%) than non-smokers (36%). Among participants who completed the study the rate of compliance was
72%. The highest rates of dropouts occurred between the first and second treatment visits in both smokers (38%
dropout) and non-smokers (18% dropout). Throughout the study smokers were more likely to dropout than
non-smokers. Black tea treatment was associated with the highest rates of dropout among smokers (37%), but was
associated with the lowest rate of dropout among non-smokers (4%).
Conclusions: In a study conducted to test the feasibility of a four-treatment crossover tea trial, a high rate of
dropout among smokers and non-smokers was observed. Multi-arm crossover tea trials might pose a higher burden
on participants and research is needed to improve adherence and treatment compliance in such trials.
Trial registration number: ISRCTN70410203Background
Crossover clinical trials, where participants serve as their
own control, afford higher efficiency in both power and
cost over parallel designs and have recently seen increas-
ing popularity in evaluating complementary and alterna-
tive medicine (CAM) therapies [1]. The efficiency and
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reproduction in any medium, provided the orparticipants’ adherence to treatment and limited attrition
during the study [2]. This is especially true in trials with
more than two arms where a greater burden is placed
on the participants. Knowledge of predictors associated
with compliance is therefore important to increase and
maintain compliance during crossover studies.
The role of tea, both green and black, in the preven-
tion of cancer is supported by evidence from a large
number of studies conducted in cell culture and in ani-
mal bioassays [3], but results of epidemiologic studies
have been inconsistent [4]. Although this discrepancy
between laboratory and epidemiologic studies under-
scores the need for chemoprevention trials of tea, only ad. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Two small trials in patients with premalignant oral
lesions demonstrated that the administration of tea
results in a reduced risk of oral cancer [5,6]. However, it
is not known whether tea has a role in the primary pre-
vention of oral cancer, and whether the effect of tea on
oral cells might be different in smokers than non-
smokers. It is also not known whether a multi-arm
crossover treatment of tea treatments will be feasible
and whether participants will comply with the treat-
ments over the comparatively long course of such a
study. A feasibility four-arm crossover trial was con-
ducted to evaluate the effect of green tea, black tea, caf-
feinated water, and placebo on cancer biomarkers in oral
cells of smokers and non-smokers without premalignant
lesions, and data on patient participation and compli-
ance in the study were analyzed.
Although reports on short-term crossover trials to as-
sess the efficacy of green/black tea for prevention of
various chronic diseases have been published in the last
few years, rates of attrition and compliance, and factors
affecting such rates have rarely been reported [7-10].
Here, dropout and compliance rates in a feasibility
crossover trial of tea are reported, and demographic and
behavioral factors associated with study dropout and
compliance are examined.
Methods
A 25-week, double-blind, four-arm crossover, feasibility
randomized trial of the effect of tea on cancer biomar-
kers in oral cells of smokers and non-smokers was con-
ducted at the Lombardi Comprehensive Cancer Center,
Georgetown University Medical Center between 2007
and 2009. Men and women between 18–60 years of age
who did not habitually drink more than two servings per
day of tea, coffee or caffeinated beverages or alcoholic
beverages were invited to participate in the study. Parti-
cipants reporting habitual consumption of less than 2
cups/day of tea or coffee were eligible to be part of the
study. Subjects with oral lesions, allergies to tea/coffee,
cancer or under advisement not to take excessive caf-
feine were ineligible for the study. Recruitment strat-
egies, utilizing flyers posted at various common areas in
the Georgetown University campus, aimed at equal
numbers of smoking (at least 10 cigarettes/day) and
non-smoking participants. Both participants and study
staff were blinded to the assigned treatment. The trial
protocol and study procedures were approved by the
Georgetown University institutional review board.
After providing informed consent, participants under-
went a three week run-in prior to starting the regimen.
During the run-in period the participants were asked
not to consume tea, coffee or other caffeine-containing
beverages. Participants were not assigned placebo duringthe run-in period and no attempt was made to assess
compliance during the run-in period. Smokers and non-
smokers were then randomized to a crossover treatment
regimen of green tea, black tea, caffeinated water, and
placebo (containing all elements of the tea beverages ex-
cept the tea). The randomization was stratified by smok-
ing status. Participants were assigned four weeks of each
treatment with two weeks of washout between each of
the four crossover treatments (Figure 1). At baseline and
each follow-up visit the participants completed study
questionnaires and oral cells were collected for bio-
marker measurements. The participants underwent clin-
ical examination and oral health evaluation at each visit
to ensure no adverse effects from the treatments. The
frequency, interval, and duration of the treatments were
determined based on previous pilot trials of tea [5,6].
The treatments were provided in standardized coded
packets manufactured by Mitsui Norin Co., Ltd., Tokyo,
Japan. There was 400 mg of tea powder in each of the
packets containing green/black tea. Each caffeinated
water packet contained caffeine equivalent to that in a
cup of green tea. The treatments were designed to make
the color and taste of the four treatments as similar to
each other as possible to preserve participant blinding.
Formal studies were not conducted to determine whether
the tea treatments were actually indistinguishable from
each other in taste. The bioactive and chemopreventive
components of green and black tea are primarily attribu-
ted to polyphenolic compounds in tea. While catechins,
specifically Epigallocatechingallate (EGCG), are the most
abundant polyphenols in green tea, theaflavins are more
abundant in black tea. The composition of polyphenols in
each packet of tea is shown in Table 1. Participants were
instructed to drink 5 packets per day and were asked to
dissolve the contents of the treatment packet in a cup
of cold water prior to consumption. Participants were
instructed to follow a specified protocol including drink-
ing two cups in the morning, 2 cups in the afternoon, and
1 cup after dinner. A standard method of drinking was
prescribed whereby participants were instructed to drink
by mouthfuls, holding each mouthful for 30 seconds to 1
minute to facilitate the uptake of tea in the oral cells.
During the course of the study each participant was
assigned to the four tea treatments with the order of
treatments determined by the randomization schedule.
A total of 140 packets were provided for each treatment
of the crossover regimen – five packets per day for four
weeks. After four weeks, participants were instructed to
return the empty packets which were then tallied and
recorded by one of the trial coordinators. Compliance
was measured by the number of empty packets returned
to the trial coordinator after each crossover treatment.
The proportion of packets returned out of the 140 pack-
ets distributed for each phase of the crossover was
Run-in Treatment 1* Treatment 2* Treatment 3* Treatment 4*Washout Washout Washout
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Figure 1 Study design schema of the 25-week crossover tea study. Legend: * Treatments: Green tea, Black tea, Caffeinated water, and
Placebo
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least 85% of empty packets for each treatment were clas-
sified as “compliant”. Participants who did not complete
all four crossover treatments were classified as dropouts
from the study.
Data on demographics, smoking habits, and usual in-
take of tea, coffee, carbonated beverages, alcohol, and fruit
and vegetables were recorded on questionnaires adminis-
tered at baseline. Body mass index (BMI) of participantsTable 1 Composition of tea packets in the crossover tea
study
Component Green tea Black tea












Theaflavin 3-O-gallate - 0.5
Theaflavin 3’-O-gallate - 0.3
Theaflavin 3,3’-di-O-gallate - 0.4
Caffeine 5.4 7.1
Gallic acid 0.2 0.9was also calculated from height and weight measured at
baseline.
Statistical analysis: Analyses were conducted to deter-
mine factors associated with treatment compliance and
study dropout. Association of dropout/compliance status
with participant characteristics were based on univariate
generalized linear models for the continuous variables,
and the chi-square test for the categorical variables. For
comparisons with sparse categorical data (N< 5) we
used the Fisher’s exact test for tests of significance.
Results
Thirty two current smokers (≥10 cigarettes/day) and 33
non-smokers were randomized to the four crossover
treatments. The participation rate for the trial was 76%
for current smokers, and 94% for non-smokers. The flow
of participants along the trial is detailed in Figure 2. At
the end of the trial period, the attrition rate across the
four crossover treatments was 51% (33 participants). Of
those who completed the study, 28% (9 participants)
returned less than 85% of the packets for at least one
treatment and were classified as “non-compliant”.
Characteristics of the participants by attrition status
are presented in Table 2. Dropouts were more likely to
be African American and current smokers, and less likely
to be Asian and regular tea/coffee drinkers as compared
to participants who completed the study. However, only
the difference between smokers and non-smokers was sta-
tistically significant (Table 2).
Among those who did not dropout, participants who
were non-compliant (returned <85% empty packets for at
least one treatment) were more likely to be younger, fe-
male, never smokers, and have normal BMI as compared
Assessed for eligibility (n=77 )
Excluded (n=12)
Not meeting inclusion criteria (n=3)



























































Followed by crossover to the other three treatments
determined by the randomization sequence
Followed by crossover to the other three treatments
determined by the randomization sequence
Figure 2 Participant flow diagram.
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also less likely to be regular tea and coffee drinkers than
compliant participants. However, none of the differences
were statistically significant.
Attrition data classified by treatment number (1 through
4) and treatment type (green tea, black tea, caffeinated
water, and placebo) for current smokers and non-smokers
are shown in Table 4. Attrition was highest between the
first and second treatments (between weeks 3 and 7)
among both smokers and non-smokers. However, dropout
rates were higher for smokers as compared to non-
smokers for all treatments/visits. For example, 38% of
smokers dropped out between the first and second treat-
ment visits as compared to 18% of the non-smokers
(Table 4).
In addition, participants dropping out of the study be-
tween treatments 1 and 2 were classified as “early drop-
outs” and those that dropped out after receiving
treatment 2 packets as “late dropouts”. Baseline charac-
teristics between early and late dropouts were compared
(Table 5). Compared to late dropouts, early dropouts
were more likely to be African-American and less
likely to report regular consumption of tea or coffee
(0.10 ≤ P <0.15 for these comparisons). Among those
who completed the treatment, compliance was slightly
higher among smokers as compared to non-smokers
but the difference was not statistically significant (data not
shown).Association of a particular treatment (green tea/black
tea/caffeinated water/placebo) with attrition/compliance
was also examined (Table 4). The dropout rates for
green tea, black tea, and placebo were higher for smo-
kers than non-smokers. However, the difference was sta-
tistically significant only for black tea (Table 4). The
rates for caffeinated water were similar between smokers
and non-smokers. Current smokers were most likely to
drop out when the assigned treatment was black tea as
compared to other treatments. This was contrary to the
experience among non-smokers who were least likely to
drop out when on black tea treatment (Table 4). How-
ever, among the non-smokers who completed the treat-
ments, non-compliance was higher for black tea as
compared to the other treatments (data not shown).
There were no adverse effects reported by participants
in the study except for those referring to unpleasant
taste and teeth staining reported by some participants
who dropped out of the study. Although dropouts were
not re-contacted to determine the reason for dropout,
some participants did call the study coordinators to in-
form them of their decision to drop out of the study. In
these cases, the participants were asked the reason for
dropping out of the study. Of the 33 participants who
dropped out of the trial, 4 (12%) provided a reason for
leaving the study. Of these, 2 complained of unpleasant/
bitter taste of the treatment (one patient was on green
tea and one on black tea at the time of dropping out),
Table 2 Participant characteristics by treatment completion* in the crossover tea study
Characteristic Completed (N= 32) Dropped out (N = 33)
(%) (%)












Regular alcohol intake 25 21
Regular tea intake 41 33
Regular coffee intake 52 41
Regular carbonated beverages intake 32 49
Fruit/vegetable servings/day, mean (SD) 2.4 (1.3) 2.7 (1.7)
BMI, mean (SD) 24.1 (3.6) 24.2 (5.8)
aP value <0.05 for comparison between “completed” and “dropped out”.
b 0.05≤ P value< 0.10 for comparison between “completed” and “dropped out”.
c 0.10 ≤ P value< 0.15 for comparison between “completed” and “dropped out”.
* Treatment completion is defined as completion of all four crossover treatments.
Regular intake <2 servings per day. Participants reporting ≥2 servings per day consumption of tea, coffee, carbonated beverages, or alcohol were excluded from
the trial.
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tea), and one participant complained of both unpleasant
taste and teeth staining (on black tea).
Discussion
In a 25-week crossover tea trial a very high attrition rate,
especially among smokers, was observed. The dropout
rate was highest between the first and second tea treat-
ments. Black tea treatment was associated with the high-
est rate of attrition among smokers. Demographic and
behavioral factors other than smoking, although suggest-
ive, were not statistically significantly associated with at-
trition or compliance in our study.
Few previous crossover studies have explicitly reported
on participant attrition and compliance in tea trials and
none of them have reported a dropout/non-adherence
rate as high as seen in this study [7-12]. None of those
studies had four crossover treatments, and all were sig-
nificantly shorter in duration compared to our study. In
addition, none of the studies had a smoking population
as large as this study.
Research on the association of smoking and attrition
in clinical trials is primarily based on smoking cessation
studies, which have shown that pre-inclusion (duringscreening or intake evaluations) attrition is generally
higher (in the 30-50% range) as compared to post-inclusion
(intervention or post-intervention follow-up) attrition
which varies from less than 10% to 50% [13-15]. These rates
are comparable to the rates seen in the present study. Rates
of attrition for both smokers and non-smokers in this study
were higher for the first treatment as compared to the sub-
sequent crossover treatments.
Black tea, and to a lesser extent, green tea were asso-
ciated with the highest rates of attrition among smokers
but not among non-smokers. Five smokers and three
non-smokers in the current trial complained of an un-
pleasant/bitter taste while on either the green tea or
black tea treatment. However, only one of the smokers
reported not complying as a result of taste, whereas the
others complied with the treatments. Although smoking
is common in tea houses in some cultures in Asia and
Africa, and there is no research to suggest that smoking
alters the taste of tea, it is possible that the polyphenols,
theaflavins or other substances in black tea interact with
smoking to cause a bitter taste, and might reduce the
tolerance of smokers to tea treatments. Efforts to
minimize attrition in future CAM studies of tea should
focus primarily on smokers.
Table 3 Participant characteristics by treatment compliance* among participants who completed the crossover tea
study
Characteristic Compliant (N= 23) Non-compliant (N= 9)
(%) (%)












Regular alcohol intake 22 33
Regular tea intake 44 33
Regular coffee intake 59 33
Regular carbonated beverages intake 36 22
Fruit/vegetable servings/day, mean (SD) 2.4 (1.4) 2.4 (1.0)
BMI, mean (SD) 24.9 (3.6) 22.1 (2.8)
aP value <0.05 for comparison between “compliant” and “non-compliant”.
b 0.05≤ P value< 0.10 for comparison between “compliant” and “non-compliant”.
c 0.10 ≤ P value< 0.15 for comparison between “compliant” and “non-compliant”.
* Treatment non-compliance defined as consumption of <85% of the packets provided for at least one of the four treatments.
Regular intake <2 servings per day. Participants reporting ≥2 servings per day consumption of tea, coffee, carbonated beverages, or alcohol were excluded from the trial.
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relatively high rate of non-adherence could be related to
the frequent doses of treatment (5 doses per day) that the
participants were required to take as part of the trial, theTable 4 Treatment completion* among current cigarette smo
Smokers
Total Completed Dropp
(n) n (%) n
Treatment number
1b 32 20 (62) 12
2 20 16 (80) 4
3 16 13 (81) 3
4 13 11 (85) 2
Treatment type
Green tea 18 13 (72) 5
Black teaa 22 14 (63) 8
Caffeinated water 20 17 (85) 3
Placebo 21 16 (77) 5
aP value <0.05 for difference in proportions between smokers and non-smokers.
b 0.05≤ P value< 0.10 for difference in proportions between smokers and non-smo
c 0.10 ≤ P value< 0.15 for difference in proportions between smokers and non-smo
* Treatment completion is defined as completion of all four crossover treatments.
Treatment number represents the number of the assigned crossover treatment. For e.gcrossover design, the long duration of the study (16 weeks
of treatment), the strong taste of the black and green tea,
and reports of teeth staining as mentioned by some
participants.kers and non-smokers in the crossover tea study
Non-smokers
ed out Total Completed Dropped out
(%) (n) n (%) n (%)
(38) 33 27 (82) 6 (18)
(20) 27 24 (89) 3 (11)
(19) 24 22 (92) 2 (8)
(15) 22 21 (95) 1 (5)
(28) 27 24 (89) 3 (11)
(37) 24 23 (96) 1 (4)
(15) 28 24 (86) 4 (14)
(23) 27 21 (85) 6 (15)
kers.
kers.
., treatment number 1 is the first assigned treatment after the run-in period.
Table 5 Participant characteristics by drop-out time* among those who dropped out of the crossover tea study
Characteristic Early drop-out Late drop-out
(N= 18) (N= 15)
(%) (%)










Regular alcohol intake 33 7
Regular tea intake, c 22 47
Regular coffee intake, c 33 50
Regular carbonated beverages intake 50 47
Fruit/vegetable servings/day, mean (SD) 2.8 (1.7) 2.7 (1.7)
BMI, mean (SD) 24.1 (7.1) 24.33 (3.9)
aP value <0.05 for comparison between “early drop-out” and “late drop-out”.
b 0.05≤ P value< 0.10 for comparison between “early drop-out” and “late drop-out”.
c 0.10 ≤ P value< 0.15 for comparison between “early drop-out” and “late drop-out”.
* Drop-out time categorized as “early” for those who dropped out between the first and second treatment visits, and “late” for those who dropped out after the
second treatment visit.
Regular intake <2 servings per day. Participants reporting ≥2 servings per day consumption of tea, coffee, carbonated beverages, or alcohol were excluded from
the trial.
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sample size for similar crossover tea studies would es-
sentially double, and make the crossover design less effi-
cient than the parallel design in our opinion. In addition,
lack of a carryover effect in a parallel group design and
more practical treatment administration, especially with
multiple treatments, are other advantages of the parallel
compared to the crossover trial design. Although the
washout periods included in the crossover trials of tea
are a safeguard against carryover effects, lack of know-
ledge on the intensity and duration of carryover effects
limits the utility of the washout periods. Additionally, in
most crossover trials, including the present study, wash-
out periods between treatments are of the same duration
thus assuming similar duration of carryover effects for
all treatments in the trial which might not be true. For
these reasons multi-arm chemoprevention trials of tea
might be more practical and achieve better compliance
if conducted using the parallel group design rather than
the crossover design.
Efforts to make the treatments more palatable, either
by providing the active ingredients in a pill or capsule
form or by masking the taste of tea, might improve re-
tention rates in tea trials. In addition, more research is
needed to determine the dosage required for physiologicchanges such that the strength of the tea and frequency
of intake might be modified to ensure compliance in
such trials. In this study participants were asked to drink
five packets of tea every day. Since most participants
were not habitual drinkers of tea, drinking five cups is a
burden that might have resulted in the high percentage
of dropouts seen in this study. In addition, participants
were prescribed to drink tea using a “standard method”
that asked them to hold the tea in the mouth for 30–60
seconds prior to swallowing. Although this method
ensures standardization of dose delivery to oral cells for
all participants it increases participant burden. Use of a
placebo run-in period prior to randomization is another
way to exclude participants who are less likely to be
compliant over the period of the study. A short-term
placebo run-in might be an effective way to decrease at-
trition and increase compliance in a parallel study, and
also in a crossover study because the results from this
study indicate that most of the dropouts occur after be-
tween the first and second treatments. However, partici-
pant exclusion based on a placebo run-in might limit the
generalizability of the study results if participation and
compliance are systematically associated with participant
characteristics, such as, education, socioeconomic status,
smoking, diet, and other behaviors. Crossover trials
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own control in a different time period but multi-arm
trials with assessment of more than two treatments
might make the trial lengthy and increase participant
burden.
Strengths of this study include conduct of a four-arm
crossover trial of tea that has not been previously
reported. In addition, data on participant characteristics,
compliance, and dropout was accurately measured
throughout the trial. However, this study has limitations.
Although the four treatments were designed to be as simi-
lar to each other as possible in taste and color, it might
not have led to 100% success with participant blinding be-
cause participants previously exposed to green or black
tea could have easily identified the tea treatment. In
addition, although some participants reported the cause of
non-compliance and dropout from the study, a formal at-
tempt was not made to determine the cause of dropout of
all participants who left the study early.
Conclusions
In summary, a high rate of attrition, especially among
smokers, was observed in a crossover tea trial in smo-
kers and non-smokers without premalignant oral lesions.
Further research is needed to identify factors that medi-
ate the observation of high dropout and low compliance
seen in smokers on tea treatments in clinical trials. Clin-
ical trials of tea with more than two treatments should
consider the use of the parallel design rather than the
crossover design to decrease participant burden and in-
crease compliance.
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